AβPP

ANTIBODY polyclonal manufacturer Cat# LS-B3671<br /> manufacturer: LifeSpan Biosciences immunogen = peptide corresp. to aa653-662 of human amyloid A4 protein precursor (APP) or aa1-10 of the 4K Ab peptide generated by β- and γ-secretases. liquid, PBS, azide,

AβPP (J4H9)

ANTIBODY monoclonal J4H9 manufacturer Cat# LS-B2970<br /> manufacturer: LifeSpan Biosciences immunogen = APP antibody was raised against recombinant human APP (18-289aa) purified from E. coli liquid, PBS, azide APP IgG_2b, κ APP, APLP,

APPβP2

ANTIBODY polyclonal manufacturer Cat# LS-C81701<br /> manufacturer: LifeSpan Biosciences immunogen = synthetic peptide corresp. to a region of human APPBP2 lyophilized, PBS, sucrose, affinity purified Amyloid Beta Precursor Protein (cytoplasmic Tail)-binding

APβA3

ANTIBODY polyclonal manufacturer Cat# LS-C102837<br /> manufacturer: LifeSpan Biosciences immunogen = synthetic peptide corresp. to a region of human APBA3 lyophilized, PBS, sucrose, affinity purified amyloid beta (A4) precursor protein-binding, family A, me

AβPP

ANTIBODY polyclonal manufacturer Cat# LS-C20540<br /> manufacturer: LifeSpan Biosciences immunogen = synthetic peptide of Amyloid-Beta protein 1-40 liquid, unpurified serum, azide recognizes Amyloid-β protein 1-40 (βAP), but not with either βAP 17-42 or secr

AβPP

ANTIBODY polyclonal manufacturer Cat# LS-C101427<br /> manufacturer: LifeSpan Biosciences immunogen = synthetic peptide corresp. to a region of human APP lyophilized, PBS, azide, sucrose, affinity purified APP IgG APP, APLP, AICD Autogen Bioclear Rabbit Huma

AβPP

ANTIBODY polyclonal manufacturer Cat# LS-C3658<br /> manufacturer: LifeSpan Biosciences immunogen = synthetic peptide that corresponds to a part of KPI domain in soluble APP liquid, unpurified serum, azide, glycerol recognizes soluble APP and synthetic pepti

AβPP (1B11F3)

ANTIBODY monoclonal 1B11F3 manufacturer Cat# LS-C47167 immunogen = Ni-NTA purified truncated recombinant APP expressed in E. coli strain BL21 (DE3) liquid, affinity purified rhAβPP IgG_2a APP, APLP, AICD Autogen Bioclear Mouse Human A&#94

PAPER Jiang H, Wu YC, Nakamura M, Liang Y, Tanaka Y, Holmes S, Dawson VL, Dawson TM, Ross CA, Smith WW

Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.

Neurobiol Aging. 2007 Nov;28(11):1709-17. PubMed: 16978743

PAPER Dalfó E, Ferrer I

Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases.

Neurobiol Aging. 2008 Mar;29(3):408-17. PubMed: 17166629

PAPER Lincoln SJ, Ross OA, Milkovic NM, Dickson DW, Rajput A, Robinson CA, Papapetropoulos S, Mash DC, Farrer MJ

Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy.

Parkinsonism Relat Disord. 2007 Aug;13(6):340-2. PubMed: 17291816

PAPER Stichel CC, Zhu XR, Bader V, Linnartz B, Schmidt S, Lübbert H

Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage.

Hum Mol Genet. 2007 Oct 15;16(20):2377-93. PubMed: 17412759

PAPER Kéri S, Nagy H, Myers CE, Benedek G, Shohamy D, Gluck MA

Risk and protective haplotypes of the alpha-synuclein gene associated with Parkinson's disease differentially affect cognitive sequence learning.

Genes Brain Behav. 2008 Feb;7(1):31-6. PubMed: 17451452

PAPER Cambrea LR, Haque F, Schieler JL, Rochet JC, Hovis JS

Effect of ions on the organization of phosphatidylcholine/phosphatidic acid bilayers.

Biophys J. 2007 Sep 1;93(5):1630-8. PubMed: 17483164

PAPER Esposito A, Dohm CP, Bähr M, Wouters FS

Unsupervised fluorescence lifetime imaging microscopy for high content and high throughput screening.

Mol Cell Proteomics. 2007 Aug;6(8):1446-54. PubMed: 17510051